Vaginal Dryness After Cancer Treatment

Estrogen keeps the vaginal lining thick, stretchy, and moist. It also keeps blood flow steady and keeps the tissue acidic. Cancer treatment can drop estrogen fast. The lining then becomes thin and pale. The rugae, which are the normal folds inside the vagina, flatten out. Natural lubrication falls.

Clinicians group these changes under one label: genitourinary syndrome of menopause, or GSM. GSM covers vaginal dryness plus bladder symptoms. Those include burning when you urinate, sudden urgency, and repeat urinary tract infections. StatPearls reports that GSM affects 27% to 84% of women after menopause.

One measurable sign is vaginal pH, a score for how acidic the tissue is. Before menopause it usually sits between 3.5 and 5.0. In GSM it rises above 5.0 when no infection is present. On exam, a clinician may see pale smooth tissue, lost folds, small cracks, and an opening that has narrowed.

Naming your route helps the team pick the right fix.

Chemotherapy. Some drugs damage the ovaries. That can cause primary ovarian insufficiency, meaning the ovaries stop making estrogen early. Periods may become irregular or stop, and dryness follows.

Pelvic radiation. Radiation to the pelvis lowers estrogen and also injures the vaginal wall directly. NCI lists vaginal stenosis, meaning a vagina that gets narrower, shorter, and less elastic. It also lists vaginal atrophy, meaning a thin wall and weak muscles, plus itching and burning.

Endocrine therapy. Aromatase inhibitors block estrogen production. The three named by NCI are anastrozole, letrozole, and exemestane. Tamoxifen and toremifene act on the estrogen receptor instead. NCI lists hot flashes, night sweats, disrupted periods, and loss of interest in sex among the effects. These drugs are often taken for five years or longer.

Surgery and transplant. Taking out both ovaries ends estrogen production that same day, with no gradual taper. After a stem cell transplant, graft-versus-host disease can scar the vagina. NCI names both radiation and graft-versus-host disease as reasons a dilator may be advised.

Lubricants come first. These go on right before sex. Choose a water-based or silicone gel with no perfume, dye, flavor, spermicide, or herbal add-in. ACS warns against petroleum jelly, skin lotion, and other oil-based products, which can lead to yeast infections. Skip anything with nonoxynol-9, a spermicide that irritates the vagina and can make pain worse.

Moisturizers are a separate product. They are used several times a week whether or not you have sex, and they absorb best at bedtime. They do not make things slippery enough for penetration on their own. StatPearls cites World Health Organization advice to pick products whose concentration, called osmolality, stays under 1200 mOsm/kg.

Dilators and pelvic floor therapy come next. A vaginal dilator is a smooth tube used to keep the vagina open and flexible. ACS advises using one several times a week to stop scar tissue from tightening things, then moving up a size as the tissue stretches. Pelvic floor physical therapy teaches you to relax those muscles rather than only squeeze them, which cuts pain at the opening.

Prescription options come last. Low-dose vaginal estrogen comes as a cream, tablet, insert, or ring, and StatPearls notes symptoms usually improve in two to four weeks. Prasterone is a small vaginal insert, a form of DHEA, used nightly. Ospemifene is a daily pill taken by mouth. Both need a prescription, and after a hormone-sensitive cancer your oncologist should be the one deciding whether either is safe for you.

This is the part that needs a real conversation, not a web search. StatPearls describes an FDA labeling contraindication for vaginal estrogen in women with a history of breast cancer. It also notes that the American College of Obstetricians and Gynecologists supports use when non-hormonal steps have failed. Prasterone carries a caution, because estrogen is one of the substances it breaks down into, but it is not contraindicated. Ospemifene is not recommended after breast cancer, because it has not been studied enough in that group.

So the answer turns on your cancer type, your receptor status, and which drug you take now. Bring the drug name to the visit. "I take letrozole for ER-positive breast cancer" starts a useful conversation. "I had breast cancer" does not.

Laser and radiofrequency devices are marketed for these symptoms, often for cash. StatPearls is blunt about the evidence: none are approved by the FDA specifically to treat GSM, and both safety and benefit remain uncertain. If a clinic offers this, ask what the device is actually cleared for, what it costs you out of pocket, and what happens if symptoms return.

• Call your care team the same day if you have any bleeding or spotting after menopause. MedlinePlus lists this under reasons to contact a provider. Do not assume it is only dryness.
• Call your care team straight away, day or night, if you have a temperature of 100.4 degrees F, or 38 degrees C, or higher while on chemotherapy. The CDC calls fever during chemotherapy a medical emergency, because your white cell count may be too low to hold an infection back. If you cannot reach them quickly, go to an emergency department. Say that you are on chemotherapy, and do not take a fever reducer first, since it can hide how ill you are.
• Call 911 or go to an emergency department if fever comes with shaking chills, confusion, breathlessness, or a racing pulse, which can point to sepsis.
• Call your care team the same day if it hurts when you urinate, or your urine is cloudy or bloody. NCI lists both as infection signs during treatment.
• Call your care team the same day if a dilator session causes tearing or bleeding. The goal is a slow stretch, not injury. Stop and report it.
• Call your care team within a day or two if the stepwise plan above is not helping after a few weeks of steady use, or sex is still too painful to attempt. Ask for the referral by name rather than waiting for the next scheduled visit.

Say it plainly early in the visit, not with your hand on the door. "Sex has been painful since I started letrozole, and lubricant alone is not enough." That one sentence names the drug, the symptom, and what you already tried.

If your oncologist does not manage this, ask who does. Depending on the problem, that may be a gynecologist, a sexual medicine clinician, or a pelvic floor physical therapist. Ask for that referral by name and by specialty.

For related reading, see Sexual Health and Cancer, Cancer and Fertility, and Fertility Preservation Before Cancer Treatment.

• National Cancer Institute — Sexual Health Issues in Women and Cancer Treatment
• StatPearls (NCBI Bookshelf) — Genitourinary Syndrome of Menopause
• American Cancer Society — Managing Sexual Side Effects as a Woman with Cancer
• National Cancer Institute — Hormone Therapy for Breast Cancer
• National Cancer Institute — Infection and Neutropenia during Cancer Treatment
• MedlinePlus — Vaginal or Uterine Bleeding
• CDC — Fever and Cancer Treatment